Raymond James Financial’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
Raymond James Financial's TRIB Position: Q3 2026 in Review
Raymond James Financial sold out of Trinity Biotech (TRIB) in Q3 2026, closing a stake of 677 shares — an estimated $7.9K sold.
Raymond James Financial first reported a position in TRIB in Q4 2024 and held it in 7 quarters. The position peaked at $23.2K in Q4 2024. 10 funds tracked by Wall St. Rank hold TRIB as of Q3 2026.
- Raymond James Financial reported no remaining Trinity Biotech position as of Q3 2026 after selling out during the quarter.
- Raymond James Financial sold 677 Trinity Biotech shares in Q3 2026, an estimated $7.9K.
- Raymond James Financial first reported a position in Trinity Biotech in Q4 2024 and held it in 7 quarters.
- Raymond James Financial's Trinity Biotech position peaked at $23.2K in Q4 2024.
- 10 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.